Farshid Mirzaee, MD
Urology · Rancho Mirage, CANPI 1194969436
Payments from drug & device makers
Across 102 payments — averaging $52.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Palette Life Sciences, Inc.$1K
- Boston Scientific$1K
- Abbott$502
- Teleflex LLC$480
- Rochester Medical Corporation$218
- Intuitive Surgical$171
- plus $2K from 26 others
What the payments were for
- Travel & lodging$81915%
- Food & beverage$4,49885%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Palette Life Sciences, Inc. | 4 | $1,138 |
| Boston Scientific | 13 | $1,136 |
| Abbott | 11 | $502 |
| Teleflex LLC | 4 | $480 |
| Rochester Medical Corporation | 26 | $218 |
| Intuitive Surgical | 2 | $171 |
| Astellas Pharma US Inc | 4 | $168 |
| Mimedx Group, Inc. | 1 | $150 |
| Neotract Inc. | 1 | $150 |
| Telix Pharmaceuticals | 1 | $137 |
| Coloplast | 1 | $125 |
| Axonics, Inc. | 5 | $121 |
| Integra Lifesciences Corporation | 1 | $118 |
| Laborie Medical Technologies Corp. | 1 | $117 |
| Bayer | 4 | $86 |
| 180 Medical, Inc. | 2 | $77 |
| AbbVie | 3 | $67 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| Pfizer | 2 | $40 |
| Urogen Pharma, Inc. | 1 | $38 |
| Dendreon Pharmaceuticals LLC | 1 | $35 |
| Olympus America Inc. | 2 | $34 |
| Urovant Sciences Inc | 1 | $26 |
| Johnson & Johnson | 1 | $21 |
| Tolmar Pharmaceuticals, Inc. | 1 | $20 |
| Endo Pharmaceuticals Inc. | 1 | $20 |
| Agile Therapeutics, Inc. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $18 |
| Therapeuticsmd, Inc. | 1 | $16 |
| Agiliti Surgical, Inc. | 1 | $14 |
| Avion Pharmaceuticals | 1 | $13 |
| Urocure LLC | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift$606
- ILLUCCIX$274
- AMS$223
- PROCLAIM$148
- Da Vinci Surgical System$131
- Isiris aStent Removal Device$125
- TACTRA$122
- SPACEOAR$118
- ADVANCE$118
- BIOFIX$118
- BIODRESTORE$118
- BIODFACTOR$118
- BIODOPTIX$118
- MEDIHONEY$118
- rezum Generator$107
- GENERAL - THERAPIES$103
How this compares
$5,317 in reported general payments places this provider in the 60th percentile of 1,324 urology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 75 | $43,075 |
| GemtesaVibegron | 19 | $14,725 |
| Tamsulosin Hcl | 520 | $8,048 |
| Testosterone | 32 | $7,702 |
| Finasteride | 360 | $5,101 |
| Mirabegron ErMirabegron | 11 | $4,706 |
| Testosterone Cypionate | 62 | $1,920 |
| Oxybutynin Chloride ErOxybutynin Chloride | 84 | $1,902 |
| Methenamine Hippurate | 22 | $1,501 |
| Potassium Citrate ErPotassium Citrate | 13 | $1,414 |
| Ciprofloxacin Hcl | 275 | $1,044 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 119 | $831 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 35 | $763 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 41 | $742 |
| Bicalutamide | 15 | $350 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $168 | $43,07575 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $42 | $14,72519 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,324 urology providers in California.
Other urology in Rancho Mirage
- Edward UchioOrange$21.1M
- Stephen FreedlandWest Hollywood$16.7M
- Alec KooTorrance$7.4M
- Karim ChamieLos Angeles$4.3M
- Ralph ClaymanOrange$3.9M
- Siamak DaneshmandLos Angeles$3.5M
- Arnold ChinLos Angeles$3.5M
- Roger LiLoma Linda$2.3M
- John KowalczykLos Angeles$1.8M
- Arie BelldegrunLos Angeles$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.